Showing posts with label Molecular Diagnostic Market. Show all posts
Showing posts with label Molecular Diagnostic Market. Show all posts

Wednesday, 28 March 2018

Europe Molecular Diagnostic Market For Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products Market Will Expand At A CAGR Of 11.6% From 2015 To 2023 To Reach US$ 22.3 Mn

Researchmoz added Most up-to-date research on "Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products (Polymerase chain reaction, Non-amplified tests, and Isothermal nucleic acid amplification technology; Hospitals, Public health laboratories, and Others) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023" to its huge collection of research reports.

Nucleic acid tests are used for rapid and accurate identification of microbes. This report on molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products in Europe analyses the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the nucleic acid test products market in Europe with respect to the leading market segments based on type of test techniques, end-user, and geography.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=667909

The market overview section of the report includes qualitative analysis of the nucleic acid test product market in Europe including the factors determining the market dynamics such as drivers, restraints, and opportunities, along with Porter’s Five Forces Analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players have been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the European market.

The nucleic acid test product market in Europe has been segmented based on type of test technique, end-user, and geography. Based on type of test technique, the nucleic acid test market has been categorized into three major segments: polymerase chain reaction, non-amplified tests, and isothermal nucleic acid amplification technology. Based on end-user, the nucleic acid test product market in Europe has been segmented into five types: Hospitals, public health laboratories, and others. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 is provided for all the segments, considering 2014 as the base year.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/molecular-diagnostics-market-europe-industry-analysis-size-share-growth-trends-and-forecast-2015-2023-report.html/toc

Geographically, the nucleic acid test product market in Europe has been categorized into five regions: Western Europe, Northern Europe, Southern Europe, Eastern Europe, and Rest of Europe. Western Europe comprises France, Germany, Austria, and Rest of Western Europe. Northern Europe includes Ireland, Norway, Sweden, the U.K. and Northern Ireland, and Rest of Central Europe. Southern Europe comprises Italy, Spain, Portugal, and Rest of Southern Europe. Eastern Europe comprises Poland, the Czech Republic, Ukraine, Russian Federation, and Rest of Eastern Europe. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the market. The report also profiles major players in the nucleic acid test product market in Europe based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Alere, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc., Nanosphere, Inc., and Quidel Corporation.

The molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests in Europe has been segmented as follows:

European Molecular Diagnostic Market for Group A Streptococcus (GAS)

- Nucleic Acid (NA) Tests Products, by Type of Technique
- Isothermal nucleic acid amplification technology (iNAT)
- Polymerase chain reaction
- Non-amplified Tests

European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products, by End-user

- Hospitals
- Public Health Laboratories
- Others (referenced and clinical laboratories)

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=667909

European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products, by Geography

- Northern Europe
- Ireland
- Norway
- Sweden
- United Kingdom of Great Britain and Northern Ireland
- Eastern Europe
- Eastern Europe
- Ukraine
- Poland
- Czech Republic
- Russian Federation
- Rest of Eastern Europe
- Western Europe
- France
- Germany
- Austria
- Rest of Western Europe
- Southern Europe
- Italy
- Spain
- Portugal
- Rest of Southern Europe
- Rest of Europe (including Scandinavia, Mediterranean Europe, and Azerbaijan)

Sunday, 22 January 2017

Global Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Industry Trends and Forecast 2014 - 2020

Researchmoz added Most up-to-date research on "Molecular Diagnostic Market For Group A Streptococcus (GAS) NA Tests - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020" to its huge collection of research reports.

Group A Streptococcus (GAS) is a type of gram-positive B-hemolytic Streptococcus bacteria. These bacteria are capable of causing a wide range of both non-invasive and invasive infections. GAS infection might spread through direct contact with skin sores or mucus of a infected person. Despite the emergence of wide range effective and safe antibiotics as a treatment regimen for GAS, infection caused by GAS is increasing significantly across the world. However, with the use of advance molecular diagnosis kits and technologies, the progression of the infections can be slowed down to a significantly, which will ultimately reduce the recovery time of the patient.  Currently, molecular diagnostic market for GAS NA test is a lucrative market venture due to high patient preference and increasing base of patients suffering from Streptococcal infections, which makes this industry a highly profitable and attractive market.

Some of the molecular diagnostic techniques generally used for group A Streptococcus (GAS) NA tests are as follows:

- Rapid antigen testing techniques
- Rapid chromatographic immunoassay testing techniques
- In vitro diagnostic testing techniques
- RT-PCR based techniques

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=209074

In the geographical analysis, North America is the largest market for molecular diagnostic kits for group A Streptococcus tests owing to the high incidence rate of Streptococcal infections and diseases. According to the Centers for Disease Control and Prevention (CDC), each year, nearly 11,000 people suffer from invasive GAS infections and approximately 10 million people suffer from non-invasive GAS infections, in the U.S.

However, other regions such as South East Asia, Latin America and Middle East are expected to be the promising markets in the near future. Owing to the rising disposable income among population and high adoption rate for advanced molecular diagnostics kits and technologies, these regions are expected to be the potential market in the near future.

The overall molecular diagnostic market for group A Streptococcus (GAS) NA tests is experiencing an admirable growth; due to the increasing incidence rate of group A Streptococcus infections, such as pharyngitis, tonsillitis and fever. Moreover, large base of patients affected from streptococcal infections including both geriatric population and youth is expected to drive the growth of various molecular diagnostic kits that are used for group A Streptococcus tests. It has also been estimated that, this market is shows potential to be a lucrative and expanding field due the increasing adoption rate for advanced diagnostic technologies and services. Expected technological breakthroughs will generate abundant opportunities for molecular diagnostic kits that could be used for detecting targeted Streptococcal bacteria, which causes the infections. For instance, Japan based Otsuka Pharmaceutical Co., Ltd. launched a rapid diagnostic test kit, \"QuickNavi Strep A\" for rapid detection of beta-hemolytic group A Streptococcus on 14 April 2014.

However, rise in overall healthcare expenditure, stringent reimbursement policies and high development costs are some of the market-restraining factors that might hinder the growth of molecular diagnostic kits market for group A Streptococcus (GAS) NA tests in future.

Currently, the molecular diagnostic market for Group A Streptococcus (GAS) NA tests is a highly fragmented market owing to the involvement of many established and emerging players in the market. Some of the companies involved with development and commercialization of amplification and detection platforms for performing these tests are Abbott Laboratories, Applied Biosystems, Bio-Rad Laboratories, Inc., bioMérieux, Cepheid, Inc., Digene Corporation, Otsuka Pharmaceutical Co., Ltd., Qiagen, Roche Diagnostics Corporation, Siemens AG and Stratagene Corporation (Agilent Technologies Inc.)

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

- North America
- Asia Pacific
- Europe
- Rest of the World 

This report provides comprehensive analysis of

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=209074

Wednesday, 16 November 2016

European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products expected to reach US$ 22.3 Mn in 2023

Researchmoz added Most up-to-date research on "Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products (Polymerase chain reaction, Non-amplified tests, and Isothermal nucleic acid amplification technology; Hospitals, Public health laboratories, and Others) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023" to its huge collection of research reports.

Nucleic acid tests are used for rapid and accurate identification of microbes. This report on molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products in Europe analyses the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the nucleic acid test products market in Europe with respect to the leading market segments based on type of test techniques, end-user, and geography.

The market overview section of the report includes qualitative analysis of the nucleic acid test product market in Europe including the factors determining the market dynamics such as drivers, restraints, and opportunities, along with Porter’s Five Forces Analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players have been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the European market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=667909

The nucleic acid test product market in Europe has been segmented based on type of test technique, end-user, and geography. Based on type of test technique, the nucleic acid test market has been categorized into three major segments: polymerase chain reaction, non-amplified tests, and isothermal nucleic acid amplification technology. Based on end-user, the nucleic acid test product market in Europe has been segmented into five types: Hospitals, public health laboratories, and others. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 is provided for all the segments, considering 2014 as the base year.

Geographically, the nucleic acid test product market in Europe has been categorized into five regions: Western Europe, Northern Europe, Southern Europe, Eastern Europe, and Rest of Europe. Western Europe comprises France, Germany, Austria, and Rest of Western Europe. Northern Europe includes Ireland, Norway, Sweden, the U.K. and Northern Ireland, and Rest of Central Europe. Southern Europe comprises Italy, Spain, Portugal, and Rest of Southern Europe. Eastern Europe comprises Poland, the Czech Republic, Ukraine, Russian Federation, and Rest of Eastern Europe. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the market. The report also profiles major players in the nucleic acid test product market in Europe based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Alere, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc., Nanosphere, Inc., and Quidel Corporation.

The molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests in Europe has been segmented as follows:

European Molecular Diagnostic Market for Group A Streptococcus (GAS)

- Nucleic Acid (NA) Tests Products, by Type of Technique
- Isothermal nucleic acid amplification technology (iNAT)
- Polymerase chain reaction
- Non-amplified Tests

European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products, by End-user
- Hospitals
- Public Health Laboratories
- Others (referenced and clinical laboratories)

European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products, by Geography

- Northern Europe
- Ireland
- Norway
- Sweden
- United Kingdom of Great Britain and Northern Ireland
- Eastern Europe
- Eastern Europe
- Ukraine
- Poland
- Czech Republic
- Russian Federation
- Rest of Eastern Europe
- Western Europe
- France
- Germany
- Austria
- Rest of Western Europe
- Southern Europe
- Italy
- Spain
- Portugal
- Rest of Southern Europe
- Rest of Europe (including Scandinavia, Mediterranean Europe, and Azerbaijan)

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=667909

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...